feed,title,long_url,short_url
Benzinga,"NGM Biopharmaceuticals EVP Acquires 615,000 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/11/35702163/ngm-biopharmaceuticals-evp-acquires-615-000-shares-after-exercising-company-stock-options,https://da.gd/rwYRkp
Benzinga,Chief Executive Officer at NGM Biopharmaceuticals Exercises Options Worth $2.24M,https://benzinga.com/news/23/11/35702160/chief-executive-officer-at-ngm-biopharmaceuticals-exercises-options-worth-2-24m,https://da.gd/hmDpdb
Benzinga,Principal Accounting Officer at NGM Biopharmaceuticals Exercises Options Worth $93K,https://benzinga.com/news/23/11/35702156/principal-accounting-officer-at-ngm-biopharmaceuticals-exercises-options-worth-93k,https://da.gd/qFrmj
Benzinga,SVP at NGM Biopharmaceuticals Exercises Options Worth $412K,https://benzinga.com/news/23/11/35702152/svp-at-ngm-biopharmaceuticals-exercises-options-worth-412k,https://da.gd/ASByh
Benzinga,"Alkami Technology Chief Legal Officer Acquires 60,000 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/11/35702150/alkami-technology-chief-legal-officer-acquires-60-000-shares-after-exercising-company-stock-options,https://da.gd/uzQgl6
Benzinga,"Energy Recovery Director Acquires 289,891 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/11/35702134/energy-recovery-director-acquires-289-891-shares-after-exercising-company-stock-options,https://da.gd/7JEjr
Benzinga,"Nicolet Bankshares President & CEO Acquires 22,795 Shares After Exercising Company Stock Options",https://benzinga.com/news/23/11/35702128/nicolet-bankshares-president-ceo-acquires-22-795-shares-after-exercising-company-stock-options,https://da.gd/W3sTz
